Long-term outcome of ABO-incompatible living donor kidney transplantation based on antigen-specific desensitization. An observational comparative analysis

Nephrology Dialysis Transplantation

Volumn 25, Issue 11, 2010, Pages 3778-3786

  Wilpert, Jochen ^a   Fischer, Karl Georg ^a   Pisarski, Przemyslaw ^b   Wiech, Thorsten ^c   Daskalakis, Michael ^d   Ziegler, Anna ^a   Neumann Haefelin, Elke ^a   Drognitz, Oliver ^b   Emmerich, Florian ^d   Walz, Gerd ^a   Geyer, Marcel ^a  

^a Renal Division   (Germany)

^b Transplant Unit   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

ABO incompatible; ABOi; Antigen specific immunoadsorption; Kidney transplantation; Rituximab

Indexed keywords

BASILIXIMAB; CREATININE; IMMUNOGLOBULIN; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; TACROLIMUS; AGGLUTININ;

ADULT; AGED; ANTIGEN SPECIFIC IMMUNOADSORPTION; ARTICLE; BLOOD COMPATIBILITY; BLOOD GROUP ABO INCOMPATIBILITY; CELLULAR IMMUNITY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DESENSITIZATION; DRUG DOSE REDUCTION; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HUMAN; HUMORAL IMMUNITY; IMMUNOADSORPTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; LYMPHOCELE; MALE; NEOPLASM; OBSERVATIONAL STUDY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROTEINURIA; SINGLE DRUG DOSE; TREATMENT OUTCOME; ADOLESCENT; BLOOD; BLOOD GROUP ABO SYSTEM; BLOOD GROUP INCOMPATIBILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; IMMUNOLOGY; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; AGED; AGGLUTININS; BLOOD GROUP INCOMPATIBILITY; DESENSITIZATION, IMMUNOLOGIC; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSORBENT TECHNIQUES; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 78851472196     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq229     Document Type: Article

References (23)

1. Newsletter Transplant 2008. 13: Council of Europe.
2. Stegall MD, Dean PG, Gloor JM. ABO-incompatible kidney transplantation. Transplantation 2004; 78: 635-640 (Pubitemid 39244721)
3. Montgomery RA, Locke JE, King KE et al. ABO incompatible renal transplantation: A paradigm ready for broad implementation. Transplantation 2009; 87: 1246-1255
4. Takahashi K, Saito K, Takahara S. Excellent long-Term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 2004; 4: 1089-1096 (Pubitemid 38868599)
5. Tydén G, Kumlien G, Fehrman I. Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab. Transplantation 2003; 76: 730-731 (Pubitemid 37072012)
6. Norden G, Briggs D, Cockwell P et al. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment. Xenotransplantation 2006; 13: 148-153
7. Donauer J, Wilpert J, Geyer M et al. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: A single center experience. Xenotransplantation 2006; 13: 108-110
8. Tydén G, Donauer J, Wadström J. Implementation of a protocol for ABO-incompatible kidney transplantation - A three center experience with 60 consecutive transplantations. Transplantation 2007; 83: 1153-1155 (Pubitemid 46743673)
9. Oettl T, Halter J, Bachmann A et al. ABO blood group-incompatible living donor kidney transplantation: A prospective, single-centre analysis including serial protocol biopsies. Nephrol Dial Transplant 2009; 24: 298-303
10. Haidinger M, Schmaldienst S, Koermoeczi G et al. Vienna experience of ABO-incompatible living-donor kidney transplantation. Wien Klin Wochenschr 2009; 121: 247-255
11. Genberg H, Kumlien G,Wennberg L et al. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: A 3-year follow-up. Transplantation 2008; 85: 1745-1754
12. Wilpert J, Geyer M, Pisarski P et al. On-demand strategy as an alternative to conventionally scheduled post-Transplant immunoadsorptions after ABO-incompatible kidney transplantation. Nephrol Dial Transplant 2007; 22: 3048-3051 (Pubitemid 350093468)
13. Wilpert J, Geyer M, Teschner S et al. ABO-Incompatible kidney transplantation - proposal of an intensified apheresis strategy for patients with high initial isoagglutinine titers. J Clin Apheresis 2007; 22: 314-322 (Pubitemid 351219765)
14. Kaplan A. A simple and accurate method for prescribing plasma exchange. ASAIO Trans 1990; 36: M597-M599 (Pubitemid 20367142)
15. Winters JL, Gloor JM, Pineda AA et al. Plasma exchange conditioning for ABO-incompatible renal transplantation. J Clin Apher 2004; 19: 79-85 (Pubitemid 39006612)
16. Solez K, Colvin RB, Racusen LC et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8: 753-760 (Pubitemid 351347767)
17. Ekberg H, Tedesco-Silva H, Demirbas A et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007; 357: 2562-2575 (Pubitemid 350294223)
18. United States Renal Data System. 2009 Annual data report 3: Section F, pg 570 (www.usrds.org)
19. Collaborative Transplant Study. Newsletter 2: 2009 pg 2 (www. ctstransplant.org)
20. Tanabe K, Ishida H, Shimizu T et al. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. Contrib Nephrol 2009; 162: 61-74
21. Kamar N, Milioto O, Puissant-Lubrano B et al. Incidence and predictive factors for infectious disease after rituximab therapy in kidneytransplant patients. Am J Transplant 2010; 10: 89-98
22. Grim SA, Pham T, Sankary H et al. Infectious complications associated with the use of rituximab for ABO-incompatible and positive cross-match renal transplant recipients. Clin Transplant 2007; 21: 628-632 (Pubitemid 47399427)
23. Tydén G, Genberg H, Tollemar J et al. A randomized, doubleblind, placebo-controlled study of single-dose rituximab as induction in renal transplantation. Transplantation 2009; 87: 1325-1329